Register entry
- Registered sites
- 3
- Active NDC listings
- 10
- Live patents
- 0
- Countries
- 3
- Base
- Germany
Authorisation
Registered operations
Analytical testing3Active ingredient (API) manufacture2Labelling2Finished drug manufacture2Packaging2
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Bavarian Nordic Berna GmbHRegistrant: Bavarian Nordic A/S | Oberriedstrasse 68, Th�rishaus, Bern 3174, Switzerland (CHE) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3011237656480030654 |
| Bavarian Nordic GmbHRegistrant: Bavarian Nordic A/S | Fraunhoferstra�e 13, Martinsried, 82152, Germany (DEU) | Analytical testing | 3005565792314328944 |
| Bavarian Nordic A/S | Hejreskovvej 10A, Kvistgaard, Denmark 3490, Denmark (DNK) | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3008318564306197198 |
Catalogue
Drug listings by form and route
1010 active NDC listings: 10 vaccine. By marketing category: BLA 10.
| Dosage form | NDCs |
|---|---|
| injection, suspension | 4 |
| injection, powder, lyophilized, for suspension | 2 |
| kit | 2 |
| capsule, coated | 1 |
| liquid | 1 |
| Route | NDCs |
|---|---|
| subcutaneous | 6 |
| intramuscular | 1 |
| oral | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| bavarian nordic a/s | 10 |
Catalogue
Marketed products
10| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Diluent Component | Water for Injection | liquid, subcutaneous | 50632-003BLA |
| JYNNEOS | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen | injection, suspension, subcutaneous | 50632-001BLA |
| JYNNEOS | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen | injection, powder, lyophilized, for suspension, subcutaneous | 50632-002BLA |
| JYNNEOS | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen | injection, suspension, subcutaneous | 50632-022BLA |
| JYNNEOS | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen | injection, suspension, subcutaneous | 50632-023BLA |
| JYNNEOS | Vaccinia Virus Modified Strain Ankara-Bavarian Nordic Non-Replicating Antigen | injection, powder, lyophilized, for suspension, subcutaneous | 50632-024BLA |
| RabAvert | Rabies Vaccine | kit | 50632-010BLA |
| VIMKUNYA | Chikungunya Vaccine, Recombinant | injection, suspension, intramuscular | 50632-018BLA |
| Vaxchora | Cholera Vaccine, Live, Oral | kit | 50632-015BLA |
| Vivotif | Salmonella typhi Ty21a | capsule, coated, oral | 50632-016BLA |
Compare
Comparable companies in Germany
- Boehringer Ingelheim Biopharmaceuticals China Ltd3 sites · 127 NDC
- Beiersdorf AG3 sites · 107 NDC
- Merz Pharma GmbH & Co. KGaA3 sites · 17 NDC
- Aesica Pharmaceuticals S.r.l.3 sites · 2 NDC
- BioNTech Manufacturing GmbH3 sites · 0 NDC
- Nuvisan France SARL3 sites · 0 NDC
- Corden Pharma International GmbH4 sites · 14 NDC
- Merck KGaA2 sites · 14 NDC
- Rentschler Biopharma SE2 sites · 8 NDC
- Symbiosis Pharmaceutical Services Limited2 sites · 3 NDC
Enquiry
Common questions
- Is Bavarian Nordic A/S FDA approved?
- Bavarian Nordic A/S holds 3 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Bavarian Nordic A/S's drugs manufactured?
- At registered sites in Switzerland, Germany, Denmark. The FDA register lists Th�rishaus; Martinsried; Kvistgaard. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
- What drugs does Bavarian Nordic A/S make?
- 10 products are listed under Bavarian Nordic A/S in the openFDA NDC Directory, most often as injection, suspension; injection, powder, lyophilized, for suspension; kit. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.